Hitomi Saso

1.3k total citations · 1 hit paper
11 papers, 1.0k citations indexed

About

Hitomi Saso is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Hitomi Saso has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Hitomi Saso's work include Cancer Mechanisms and Therapy (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and FOXO transcription factor regulation (2 papers). Hitomi Saso is often cited by papers focused on Cancer Mechanisms and Therapy (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and FOXO transcription factor regulation (2 papers). Hitomi Saso collaborates with scholars based in United States, Japan and United Kingdom. Hitomi Saso's co-authors include Mien‐Chie Hung, Weiya Xia, Fu Ou‐Yang, Yiyu Zou, Shilai Bao, Leonard S. Golfman, Dung‐Fang Lee, Mickey C.‐T. Hu, Norihisa Hanada and Jer-Yen Yang and has published in prestigious journals such as Cell, Cancer Research and Scientific Reports.

In The Last Decade

Hitomi Saso

11 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a

2004 742 citations Mickey C.‐T. Hu, Dung‐Fang Lee et al. Cell profile →

Peers

Countries citing papers authored by Hitomi Saso

Since Specialization

Citations

This map shows the geographic impact of Hitomi Saso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitomi Saso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitomi Saso more than expected).

Fields of papers citing papers by Hitomi Saso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitomi Saso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitomi Saso. The network helps show where Hitomi Saso may publish in the future.

Co-authorship network of co-authors of Hitomi Saso

This figure shows the co-authorship network connecting the top 25 collaborators of Hitomi Saso. A scholar is included among the top collaborators of Hitomi Saso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitomi Saso. Hitomi Saso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer 2020 ·Scientific Reports ·Maria Gagliardi, (unknown), Jihyun Park, Xuemei Xie, Hitomi Saso, Richard Larson, (unknown), Huiqin Chen, Caimiao Wei, Hiroko Masuda, (unknown), Kimie Kondo, Debu Tripathy, Naoto T. Ueno, Kevin N. Dalby, Bisrat G. Debeb, Chandra Bartholomeusz	28
2	MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model 2015 ·Molecular Cancer Therapeutics ·Chandra Bartholomeusz, Xuemei Xie, (unknown), Kimie Kondo, Ali Dadbin, Jangsoon Lee, Hitomi Saso, Paul D. Smith, Kevin N. Dalby, Naoto T. Ueno	59
3	TIG1 Promotes the Development and Progression of Inflammatory Breast Cancer through Activation of Axl Kinase 2013 ·Cancer Research ·Xiaoping Wang, Hitomi Saso, Takayuki Iwamoto, Weiya Xia, Yun Gong, Lajos Pusztai, Wendy A. Woodward, James M. Reuben, Steven L. Warner, David J. Bearss, Gabriel N. Hortobágyi, Mien‐Chie Hung, Naoto T. Ueno	65
4	PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin 2012 ·Oncogenesis ·J. Jack Lee, Chandra Bartholomeusz, (unknown), (unknown), Hitomi Saso, Tiffany A. LaFortune, G. N. Hortobagyi, Naoto T. Ueno	22
5	Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt 2011 ·Journal of Cancer ·Chandra Bartholomeusz, Fumiyuki Yamasaki, Hitomi Saso, Kaoru Kurisu, Gabriel N. Hortobágyi, Naoto T. Ueno	23
6	MEK1/2 Inhibitor Selumetinib (AZD6244) Inhibits Growth of Ovarian Clear Cell Carcinoma in a PEA-15–Dependent Manner in a Mouse Xenograft Model 2011 ·Molecular Cancer Therapeutics ·Chandra Bartholomeusz, Tetsuro Oishi, Hitomi Saso, Uǧur Akar, Ping Liu, Kimie Kondo, (unknown), Savitri Krishnamurthy, Jangsoon Lee, Francisco J. Esteva, Junzo Kigawa, Naoto T. Ueno	23
7	Safety and Efficacy of Radionuclide Therapy with High-Activity In-111 Pentetreotide in Patients with Progressive Neuroendocrine Tumors 2008 ·Cancer Biotherapy and Radiopharmaceuticals ·Ebrahim S. Delpassand, Jennifer Sims‐Mourtada, Hitomi Saso, Ali Azhdarinia, Faramarz Ashoori, (unknown), Gregory D. Espenan, Warren H. Moore, Eugene A. Woltering, Lowell Anthony	40
8	IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a 2007 ·Cell ·Mickey C.‐T. Hu, Dung‐Fang Lee, Weiya Xia, Leonard S. Golfman, Fu Ou‐Yang, Jer-Yen Yang, Yiyu Zou, Shilai Bao, Norihisa Hanada, Hitomi Saso, Ryûji Kobayashi, Mien‐Chie Hung	5
9	Double‐stranded RNA: distribution and analysis among isolates of Rhizoctonia solani AG‐2 to ‐13 2005 ·Plant Pathology ·N. Bharathan, Hitomi Saso, (unknown), (unknown), (unknown), (unknown)	27
10	IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a breakdown → 2004 ·Cell ·Mickey C.‐T. Hu, Dung‐Fang Lee, Weiya Xia, Leonard S. Golfman, Fu Ou‐Yang, Jer-Yen Yang, Yiyu Zou, Shilai Bao, Norihisa Hanada, Hitomi Saso, Ryûji Kobayashi, Mien‐Chie Hung	742
11	Growth restriction of negative-strand-RNA viruses in a rat 3Y1 cell line 1990 ·Medical Microbiology and Immunology ·Hitomi Saso, Kaoru Shimokata, Tetsuya Toyoda, Bin Gotoh, Yoshinori Nagai	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact